Premier Biomedical, Inc. (OTCMKTS:BIEI) Sees Large Drop in Short Interest

Premier Biomedical, Inc. (OTCMKTS:BIEI) was the recipient of a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 160,400 shares, a decline of 15.9% from the April 30th total of 190,800 shares. Based on an average daily volume of 4,289,000 shares, the days-to-cover ratio is presently 0.0 days.

Premier Biomedical Trading Down 16.7%

Shares of OTCMKTS BIEI opened at $0.00 on Thursday. Premier Biomedical has a 52-week low of $0.00 and a 52-week high of $0.00.

About Premier Biomedical

Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors.